Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Yale Expo attracts students who mean business

Tuesday’s Yale Entrepreneurship & Innovation Expo brought together Yale’s many entrepreneurial organizations and clubs for a three-hour meet-and-greet with one another and members of the...

| By Kelley Gipson

Tangen Biosciences inaugurates Branford facility

Connecticut Governor Ned Lamont, U.S. Sen. Richard Blumenthal, and other luminaries were on hand recently when Tangen Biosciences unveiled its new 16,300-square-foot facility at 20 Commerce Drive...

| By Kelley Gipson

Arvinas starts patient dosing of protein degrader

Arvinas has announced the initiation of patient dosing in its second clinical program. The Phase 1 clinical trial of ARV-471, an oral estrogen receptor (ER)-targeting...

| By Kelley Gipson

Yale scientists zero in on atomic tumor formation

Certain types of bacteria are capable of causing colorectal cancers, indicating that a sub-set of these cancers could be the result of infectious disease. There...

| By Kelley Gipson

BioXcel announces Defense grants re schizophrenia

BioXcel Therapeutics reports that the U.S. DoD’s CDMRP has awarded a planning grant1 as a part of its Alcohol and Substance Abuse Disorders Research Program...

| By Kelley Gipson

SpringWorks plans $115M IPO re ex-Pfizer drugs

SpringWorks Therapeutics has filed to raise $115 million in an IPO. The money will take SpringWorks through to regulatory filings for two former Pfizer drugs against...

| By Kelley Gipson

Cara licenses Enteris oral formulation technology

Cara Therapeutics has entered into a non-exclusive commercial license agreement with Enteris BioPharma, Inc. for oral formulation rights to Enteris’ Peptelligence® Technology. “We are pleased to...

| By Kelley Gipson

JAX steps up fight re opioids and rare diseases

Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a...

| By Kelley Gipson

SpringWorks appoints Frank Perier CFO

SpringWorks Therapeutics has appointed Francis (Frank) Perier, Jr. as Chief Financial Officer (CFO). Mr. Perier previously served as the CFO of Forest Laboratories, Inc. for...

| By Kelley Gipson

BI and Anderson Cancer form virtual R&D center

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for...